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The thymus leukemia (TL) alloantigens are encoded by the Tla locus, located 
1.5 centimorgans telomeric to H-2D on murine chromosome  17 (1).  Six alleles 
have been defined (Tla  ~-/) using ailoantisera and monoclonal (mc) antibodies (1, 
2). TL is a  glycoprotein of ~45,000  mol wt (45 K) expressed at the cell surface 
in  noncovalent association  with  /3-2 microglobulin.  Biochemical and  DNA  hy- 
bridization  studies  have  demonstrated  that  TL  is  structurally  homologous  to 
other class I  transplantation antigens (3-5). 
TL  has  been  defined as a  differentiation antigen  because  it  is  expressed by 
thymocytes and  some  leukemias,  but not by normal  peripheral T  lymphocytes 
(1).  In  this  report  we  demonstrate  that  splenic  T  iymphocytes,  activated  by 
alloantigen or concanavalin A (Con A), express a TL antigen that is indistinguish- 
able from that expressed by thymocytes, and a  leukemia line as assessed by two- 
dimensional (2-D) gel analysis. 
Materials and Methods 
Mice.  A/J and C57BL/6 (B6) mice were purchased from The Jackson Laboratory, Bar 
Harbor, ME. BALB/cCrgl mice were purchased from the Department of Cell Biology, 
Baylor College of Medicine. All other strains were from our breeding colony at Baylor 
College of Medicine. 
Antisera.  The anti-TL.m3 antibody  ~ used in this study was prepared by ammonium 
sulfate fractionation of spent culture medium from the 18/20 hybridoma line (6). Normal 
mouse serum (NMS) and polyvalent goat anti-mouse Ig (GAMIg) were purchased from 
PeI-Freez Biologicals,  Rogers, AR. 
Cell Culture.  Spleen cells  (4  ×  106/ml) were activated  with  Con  A  (2.5  ~g/ml)  in 
supplemented MishelI-Dutton medium (S-MDM) (7). After 24 h, viable cells were isolated 
by density gradient centrifugation and resuspended at 1 ×  106/ml in S-MDM containing 
added interleukin  2  (IL-2). Exogenous IL-2 was  from either a  24-h Con A-stimulated 
spleen  cell supernatant (CAS)  (final concentration 25%) or phorbol myristate acetate- 
stimulated EL4 cell supernatant that had been concentrated 20× by ammonium sulfate 
fractionation (final concentration 0.5%) (8). Con A-activated cells were passaged by a  1:2 
to  1:3 dilution in the above medium every 24 h.  For experiments examining the time 
course of appearance of TL, spleen cells  were depleted of Ig-positive lymphocytes by 
panning on affinity-purified GAMIg-coated petri dishes (9) before activation with Con A. 
* Supported in part by U. S. Public Hearth Service Grant AI 17897. 
~The  designation TL.m3 refers  to the  determinant  recognized by the  monoclonal antibody 
derived from  tbe  18/20  cell line (6). This determinant  is not necessarily the same as the TL.3 
determinant defined by alloantisera. 
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Radiolabeling and Immunoprecipitation.  Cells  were radioiodinated by the lactoperoxi- 
dase-catalyzed procedure, and detergent lysates prepared as described (10).  Aliquots of 
the precleared lysates were then incubated with anti-TL.m3 or NMS and the complexes 
precipitated with GAMIg. 
2-D Gel Electrophoresis.  Immunoprecipitates were analyzed by 2-D gel electrophoresis 
under reducing conditions using a pH 5-7 isoelectric focusing gel in the first dimension 
and a  12.5% sodium dodecyl sulfate polyacrylamide gel in the second dimension (11). 
Dried gels were exposed at -80°C to Kodak XAR-5 film in the presence of intensifying 
screens. Proteins used as molecular weight markers were bovine serum albumin (68 K), 
ovalbumin (45 K), and carbonic anhydrase (30 K). 
Flow Cytofluorometric  Analysis.  Viable cells were isolated by density gradient centrifuga- 
tion, washed, and resuspended in phosphate-buffered saline containing 0.1% sodium azide 
(PBS-azide).  106 cells were incubated with a saturating amount of TL.m3 (or medium as 
c')ntrol), washed, and then incubated with a saturating amount of fluorescein isothiocyan- 
ate (FITC)-conjugated polyvalent GAMIg. Stained cells were fixed in PBS containing 1% 
paraformaldehyde, and 10,000 cells were analyzed for fluorescence using an Epics V flow 
cytometer (Coulter Electronics Inc., Hialeah, FL). 
Results 
Time Course of  Appearance of TL on Activated Peripheral T Cells.  A/J splenocytes, 
depleted of Ig  ÷ cells by panning,  were activated with Con A  and maintained in 
culture for 6  d;  exogenous IL-2 was  added  to the cultures after 24  h  to help 
maintain  proliferation  and  cell  viability.  At  24-h  intervals,  viable  cells  were 
isolated and examined for the expression of TL by flow cytometry (Fig.  1). TL 
was not detected on unactivated splenic T  cells (0 h) and was minimally expressed 
by 24-h  Con  A  blasts.  By 48  h  and  at all  subsequent  times  analyzed,  TL  was 
detected  on  a  significant  proportion  ("~40-60%)  of the  cells.  We  have  also 
detected  TL  on  5-d  mixed  leukocyte  cultures  maintained  in  the  absence  of 
exogenous  IL-2  and  on  cloned  long  term  T  cell  lines  (see  below).  Thus  the 
expression of TL is a  feature of both alloantigen- and Con A-activated T  cells. 
Strain  Distribution  Analysis  of TL  Expression  by  Con  A-activated  T  Cells.  To 
examine if the determinants detected by the mc anti-TL.m3 on activated periph- 
eral  T  cells are encoded  within  the  Tla  region,  we analyzed 6-d  Con  A  blasts 
from several strains,  including the Tla congenic pairs, A/J, A-Tla b, B6, and B6- 
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FIGURE  1.  Time course of appearance of TL on activated T cells. Fluorescence histograms 
of normal (0 h) and Con A-activated (24-120 h) A/J T  lymphocytes stained with mc anti- 
TL.m3. The profiles of staining with anti-TL.m3  plus FITC-GAMIg (denoted  TL) are 
compared with staining with FITC-GAMIg alone. 1014  COOK  AND  LANDOLFI  BRIEF  DEFINITIVE  REPORT 
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FIGURE 2.  Strain distribution analysis of TL expression on activated T  cells.  Fluorescence 
histograms of 6-d Con  A-activated splenocytes from various strains (A-G) and a  long-term 
B10.BR CTL line (H) stained with mc anti-TL.m3. The profiles of staining with anti-TL.m3 
plus FITC-GAMIg (denoted TL) are compared with staining with FITC-GAMIg alone. 
Tla". As shown in Fig. 2, both A/J and B6-Tla ~ Con A blasts stained for TL.m3; 
cells from the TL- (Tla b) congenic partners, A-Tla h and B6, were negative. Con 
A blasts from other TL  + strains, BALB/c (TlaC), A.CA (Tlad), and B10.P (Tla e) 
also expressed the TL.m3 determinant.  2 We have examined four B10.BR (Tla")  - 
derived long-term cytotoxic T  lymphocyte (CTL) lines for the expression of TL 
and each was positive; a representative fluorescence profile of one line is shown 
in Fig.  2 H.  These data demonstrate that the determinants detected with anti- 
TL.m3 on activated peripheral T  cells are encoded by the Tla region. 
2-D Gel Analysis of TL Immunoprecipitated  From a Leukemia  Cell Line,  Thymocytes, 
and Con A-activated Peripheral  T  Cells.  Fresh B6-Tla a thymocytes, ASL-1  leuke- 
mia cells (1), and 6-d Con A  blasts from B6-Tla ~ and B6 were radioiodinated; 
aliquots of the cell lysates were immunoprecipitated with anti-TL.m3  or NMS 
and analyzed on 2-D gels (Fig.  3).  Two sets of proteins of --,47  K and -~39 K 
mol  wt  were  specifically precipitated  with  anti-TL.m3  from  ASL-1,  B6-Tla ~ 
thymocytes, and Con A blasts, but not from the control B6 Con A blasts. Neither 
series of proteins represents the Qa-1 antigen as determined by 2-D gel analysis 
of anti-Qa-1  precipitates  from normal splenocytes (unpublished observations). 
Although the relationship between the 47  K and 39  K moi wt forms of TL is 
not clear, both  have been reproducibly isolated from Tla a cells with the anti- 
TL.m3 antibody and with alloantisera. Based on both the size and charge, the 
TL molecules isolated from Con  A  blasts are identical to  those isolated from 
thymocytes and the ASL-1 leukemia cell line. 
Discussion 
The  Qa-Tla  region  encodes  a  series  of cell  surface  antigens  restricted  in 
expression to cells of the hematopoietic lineage (1).  While the Qa-l-6 antigens 
are  expressed  on  subpopulations  of peripheral  T  cells,  the  TL  antigen  has 
generally been  regarded as  a  cell  surface antigen  restricted in  expression  to 
2 The  BALB/c strain  (Tla r) was  initially described  as  negative for  the  TL.m3  determinant  as 
assessed by complement-mediated cytotoxicity (6). We have found that BALB/cCrgl tbymocytes and 
Con A blasts are weakly positive for TL.m3, using more sensitive flow cytometric analysis.  Alterna- 
tively, there may be differences among BALB/c subtines in the expression of TL specificities as has 
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FIGURE 3.  Two-dimensional gel analysis  of the  TL alloantigen.  ASL-1  cells,  B6-Tla ~ thy- 
mocytes,  6-d  B6-Tla a  Con  A  blasts,  and  6-d  B6  Con  A  blasts  were  radioiodinated  and 
immunoprecipitated with mc anti-TL.m3 (A-D) or NMS (E-H).  The basic end of the gel is at 
the  left and  the acidic end  is at  the  right.  Equivalent portions of each autoradiogram  are 
presented.  Downward and  upward slanting arrows point to the  ~47  K and  ~39  K tool wt 
forms of TL, respectively. Radioactive CPM loaded on each gel and exposure times were as 
follows: A (350,000;  10 h), B (89,000;  84 h),  C (99,000; 48 h), D (83,000;  48 h), E (112,000; 
10 h), F (55,000; 84 h); G (96,000; 48 h), H (115,000; 48 h). 
thymocytes (1).  Using the sensitive techniques of flow cytometry and  2-D gel 
analysis, we have demonstrated that activated peripheral T  lymphocytes from 
normal mice also express the TL alloantigen. 
The TL antigen expressed by Con  A-activated B6-Tla ~ splenocytes appears 
identical to that expressed by B6-Tla a thymocytes and the leukemia line ASL-1, 
based  On  migration  in  2-D  gel electrophoresis.  Both  the  mc anti-TL.m3  and 
conventional anti-TL ailoantisera (not shown) specifically precipitated two sets 
of cell surface iodinated proteins of "~47 K and  "--39  K mol wt from all  three 
cell  sources.  Previous  studies  by others  (12,  13)  have  detected only one  cell 
surface  species  (45-48  K  range)  precipitated  by  anti-TL  mc  antibodies  and 
alloantisera. The "-,39 K mol wt form probably does not represent cytoplasmic 
TL because the cells were cell surface-labeled by the lactoperoxidase-catalyzed 
procedure, and also because there is charge heterogeneity, which is not routinely 
observed for cytoplasmic forms of molecules. The  ,~39  K mol wt species may 
(a) possess the same polypeptide backbone as the "--47 K mol wt form but fewer 
carbohydrate side chains, (b) represent a proteolytic fragment of the ~47 K mol 
wt molecule, or (c) be the product of a second distinct Tla gene. Goodenow et 
al. (5) have demonstrated there are at least two Tla genes in the BALB/c genome. 
Experiments to address the structural relationship between the ~39 K and ~-47 
K mol wt forms of TL are underway. 
The expression of TL on peripheral lymphocytes has been reported in  two 
other instances.  ---20-35%  of spleen and lymph node cells from BALB/c mice 
exposed to total lymphoid irradiation express TL determinants (14). TL was not 
detected on  peripheral  cells  if the  animals  were  thymectomized before  total 
lymphoid irradiation. In the other study, Ranges et al. (15) reported that up to 
10 wk of age,  "~100% of nu/nu  splenic T  cells were TL+; by  16 wk of age the 1016  COOK  AND  LANDOLFI  BRIEF  DEFINITIVE  REPORT 
percentage of TL  + cells decreased to 8-10%.  If there is a common mechanism 
that induces or allows the expression of TL on peripheral cells in these two types 
of abnormal mice, it is not clear.  In  the total lymphoid irradiation model, an 
intact thymus is required, but in ~tu/~u mice it is not. However, in both of these 
experimental systems the hormonal signals and microenvironments important to 
cellular differentiation and trafficking are undoubtably altered from the norm 
and thus may influence the expression of TL. 
As described in this study, normal splenic T  cells that have been activated in 
vitro with alloantigen or Con A express the TL antigen. TL was not detected on 
T  cells isolated directly from the spleen but was detectable 48 h after activation 
with  Con  A.  This  TL  + phenotype was  retained  for  the  duration  of in  vitro 
culture (8-10 d). We have also examined several long-term cloned CTL lines of 
the Tla" genotype and each has been TL  +. These cell lines are Ly-l-2+; we are 
extending our analyses to cloned lines of other Ly phenotypes to determine if 
TL  expression  is  a  general  feature  of all  or  only specific  subpopulations  of 
activated T  cells.  Although our data and that of others (1) indicate that normal 
resting peripheral T  cells are TL-, these cells  may express low levels of TL not 
detected  in  most  analyses.  Scollay et  al.  (16)  have  reported  that  the  TL.m3 
determinant is detectable by flow cytometry on  10-20%  of normal peripheral 
lymphocytes; these cells are weakly TL  + and may represent a normal subpopu- 
lation of resting T  cells or T  cells that have been activated in vivo. 
Both spontaneous and  radiation-induced leukemias can  express  TL (1).  In- 
cluded among these are leukemias derived from Tla b strains that do not express 
detectable TL determinants on thymocytes. We have not as yet observed TL on 
activated cells from mice of the Tla ~' genotype using anti-TL alloantisera, which 
potentially have reactivity for TL determinants known to be anomalously ex- 
pressed on the TlaCderived leukemias. This implies that there is not a requisite 
association between cellular activation and TL expression, but a definitive answer 
awaits  testing with  other  alloantisera and  mc  antibodies.  Whether  there  is  a 
central differentiative or functional state responsible for the expression of TL 
on thymocytes, activated peripheral T  cells, certain leukemias, and peripheral T 
cells from total lymphoid irradiated mice and nu/nu  mice, remains elusive. We 
emphasize, however, that although the expression of TL remains associated with 
differentiative events, it should no longer be considered a marker restricted to 
immature T  cells and leukemias. 
Summary 
Peripheral T  lymphocytes activated in vitro with concanavalin A (Con A) or 
alloantigens express the thymus leukemia (TL) alloantigen as assessed by staining 
with the monoclonai antibody TL.m3 and flow cytometric analysis. The deter- 
minants detected by TL.m3 on activated cells are encoded within the Tla region 
and are detected as early as 48 h after activation with Con A. Several long-term 
cloned cytotoxic T  lymphocyte lines were also examined and each expressed TL. 
By two-dimensional analysis, the TL isolated from activated peripheral cells was 
indistinguishable from that found on thymocytes and the leukemia cell line ASL- 
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